Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 316 AL 330

Neuropsychiatric Aspects of Alzheimer Dementia: From Mechanism to Treatment

Nowrangi MA.

Psychiatr Clin North Am. 2020 Jun;43(2):383-397. doi: 10.1016/j.psc.2020.02.012. Epub 2020 Apr 22.

Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs

Avgerinos KI, Vrysis C, Chaitidis N, Kolotsiou K, Myserlis PG, Kapogiannis D.

Neurol Sci. 2020 Oct;41(10):2747-2754. doi: 10.1007/s10072-020-04427-0. Epub 2020 May 23.

Treatment Development for Alzheimer's Disease: How Are We Doing?

Lyketsos CG.

Adv Exp Med Biol. 2020;1195:19. doi: 10.1007/978-3-030-32633-3_3.

Management of cognitive decline in Alzheimer's disease using a non-pharmacological intervention program: A case report

Quail Z, Carter MM, Wei A, Li X.

Medicine (Baltimore). 2020 May 22;99(21):e20128. doi: 10.1097/MD.0000000000020128.

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF.

Neuropharmacology. 2020 Oct 15;177:108099. doi: 10.1016/j.neuropharm.2020.108099. Epub 2020 Jun 7.

Placebo effect in subjects with cognitive impairment

Ito K, Romero K.

Int Rev Neurobiol. 2020;153:213-230. doi: 10.1016/bs.irn.2020.03.032. Epub 2020 Jun 9.

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS.

JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.

Risk Reduction and Prevention of Alzheimer's Disease: Biological Mechanisms of Diet

McGurran H, Glenn J, Madero E, Bott N.

Curr Alzheimer Res. 2020;17(5):407-427. doi: 10.2174/1567205017666200624200651.

Neuroimaging Outcomes in Studies of Cognitive Training in Mild Cognitive Impairment and Early Alzheimer's Disease: A Systematic Review

Beishon L, Intharakham K, Swienton D, Panerai RB, Robinson TG, Haunton VJ.

Curr Alzheimer Res. 2020;17(5):472-486. doi: 10.2174/1567205017666200624202425.

Modifiable Lifestyle Factors in Alzheimer Disease: An Opportunity to Transform the Therapeutic Landscape Through Transdisciplinary Collaboration

Hohman TJ, Kaczorowski CC.

JAMA Neurol. 2020 Oct 1;77(10):1207-1209. doi: 10.1001/jamaneurol.2020.1114.

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK.

Life Sci. 2020 Sep 15;257:118020. doi: 10.1016/j.lfs.2020.118020. Epub 2020 Jun 27.

Neural oscillations and brain stimulation in Alzheimer's disease

Jafari Z, Kolb BE, Mohajerani MH.

Prog Neurobiol. 2020 Nov;194:101878. doi: 10.1016/j.pneurobio.2020.101878. Epub 2020 Jun 29.

Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives

Imbimbo BP, Lozupone M, Watling M, Panza F.

Expert Opin Investig Drugs. 2020 Sep;29(9):919-933. doi: 10.1080/13543784.2020.1795127. Epub 2020 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias